PolyMag transfection reagent was used as a base for cationic lipid-mediated transfection in several human cancer cells.
This paper shows the high efficiency of PolyMag transfection reagent from OZ Biosciences to transfect several human cancer cell lines.article reference: Int J Pharm. 2013 Feb 13. pii: S0378-5173(13)00106-3. doi: 10.1016/j.ijpharm.2013.01.055.
Gene delivery into human cancer cells by cationic lipid-mediated magnetofection.
Abstract
In this study, a
combination of magnetic nanoparticles (MNPs) with ethyl or methyl
functional groups together with cationic lipid
N,N-di-n-hexadecyl-N,N-dihydroxyethylammonium chloride formulated with
colipid cholesterol, upon magnetofection, enhanced DNA uptake into human
glioblastoma-astrocytoma, epithelial-like cell line U-87 MG,
hepatocellular carcinoma HepG2, cervical cancer HeLa and breast cancer
MDA-MB-231 cells. Having confirmed this, we monitored uptake of plasmid
DNA mediated by ternary magnetoplexes by fluorescence microscopy, flow
cytometry and reporter gene expression assays in the presence and
absence of a magnetic field. Our observations clearly indicate enhanced
transfection efficiency in vitro, upon magnetofection, in the presence
of serum as seen from β-Gal reporter gene expression. The observed
activity in serum suggests the suitability of MNPs for in vivo
applications. Further, we measured the transverse relaxation time (T(2))
and obtained T(2)-weighted MRI images of treated U-87 MG cells. T(2)
determined for MNP-VP-Me(22) and MNP-VP-Et(22) corresponds to 22.6±0.8ms
and 36.0±2.1ms, respectively, as compared to 47±1.7ms for control,
suggesting their applicability in molecular imaging. Our results
collectively highlight the potential of lipid-based approach to augment
magnetic-field guided-gene delivery using MNPs and additionally towards
developing intracellular molecular probes for MRI-based imaging.
Copyright © 2013 Elsevier B.V. All rights reserved.
Copyright © 2013 Elsevier B.V. All rights reserved.
No comments:
Post a Comment